Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biometry | 19 | 2019 | 562 | 2.870 |
Why?
|
Models, Statistical | 42 | 2024 | 5078 | 1.760 |
Why?
|
Data Interpretation, Statistical | 22 | 2024 | 2691 | 0.850 |
Why?
|
Neutropenia | 3 | 2018 | 884 | 0.790 |
Why?
|
Environmental Exposure | 31 | 2024 | 4443 | 0.720 |
Why?
|
Logistic Models | 29 | 2017 | 13240 | 0.660 |
Why?
|
Likelihood Functions | 17 | 2024 | 990 | 0.630 |
Why?
|
Toxicology | 9 | 2001 | 102 | 0.620 |
Why?
|
Growth | 2 | 2019 | 365 | 0.590 |
Why?
|
Cephalosporins | 1 | 2018 | 204 | 0.570 |
Why?
|
Azithromycin | 1 | 2018 | 199 | 0.550 |
Why?
|
Models, Theoretical | 10 | 2017 | 3576 | 0.540 |
Why?
|
Teratogens | 6 | 2000 | 117 | 0.530 |
Why?
|
Research Personnel | 2 | 2021 | 587 | 0.530 |
Why?
|
New South Wales | 5 | 2017 | 69 | 0.520 |
Why?
|
Neisseria gonorrhoeae | 1 | 2018 | 239 | 0.510 |
Why?
|
Child Development | 7 | 2021 | 2302 | 0.460 |
Why?
|
Gonorrhea | 1 | 2018 | 346 | 0.450 |
Why?
|
Abnormalities, Drug-Induced | 13 | 2009 | 339 | 0.440 |
Why?
|
Genome, Bacterial | 1 | 2018 | 784 | 0.430 |
Why?
|
Arsenic | 8 | 2016 | 358 | 0.420 |
Why?
|
Survival Analysis | 18 | 2016 | 10075 | 0.400 |
Why?
|
Insecticides | 9 | 2006 | 191 | 0.390 |
Why?
|
Regression Analysis | 15 | 2018 | 6340 | 0.380 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1376 | 0.370 |
Why?
|
Embryonic and Fetal Development | 4 | 1999 | 420 | 0.370 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1058 | 0.360 |
Why?
|
Hospitals, Public | 1 | 2011 | 201 | 0.350 |
Why?
|
Influenza, Human | 2 | 2011 | 1517 | 0.340 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 2110 | 0.330 |
Why?
|
Linear Models | 11 | 2017 | 5865 | 0.330 |
Why?
|
Hazardous Substances | 3 | 2008 | 153 | 0.320 |
Why?
|
Chorionic Villi Sampling | 4 | 2003 | 35 | 0.320 |
Why?
|
Bayes Theorem | 5 | 2017 | 2326 | 0.320 |
Why?
|
Geography | 2 | 2009 | 658 | 0.310 |
Why?
|
Violence | 8 | 2010 | 936 | 0.300 |
Why?
|
Spermatozoa | 9 | 2006 | 630 | 0.300 |
Why?
|
Environmental Monitoring | 8 | 2009 | 1453 | 0.290 |
Why?
|
Carcinogenicity Tests | 3 | 1996 | 38 | 0.280 |
Why?
|
Computer Simulation | 11 | 2024 | 6230 | 0.280 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2024 | 2502 | 0.280 |
Why?
|
Environmental Pollutants | 8 | 2009 | 1274 | 0.280 |
Why?
|
Body Height | 5 | 2018 | 1570 | 0.270 |
Why?
|
Pregnancy | 50 | 2024 | 29831 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2024 | 10759 | 0.260 |
Why?
|
Models, Genetic | 1 | 2016 | 3445 | 0.260 |
Why?
|
Occupational Exposure | 11 | 2015 | 1811 | 0.260 |
Why?
|
Wounds and Injuries | 3 | 2007 | 2483 | 0.260 |
Why?
|
Humans | 197 | 2024 | 760437 | 0.250 |
Why?
|
Length of Stay | 5 | 2014 | 6413 | 0.250 |
Why?
|
Limb Deformities, Congenital | 3 | 2003 | 136 | 0.250 |
Why?
|
Female | 151 | 2024 | 391875 | 0.250 |
Why?
|
Epidemics | 1 | 2011 | 512 | 0.250 |
Why?
|
Respiratory Sounds | 8 | 2008 | 701 | 0.240 |
Why?
|
Ireland | 3 | 2018 | 171 | 0.240 |
Why?
|
Case-Control Studies | 24 | 2017 | 22097 | 0.230 |
Why?
|
Multivariate Analysis | 15 | 2007 | 12054 | 0.230 |
Why?
|
Endotoxins | 5 | 2007 | 521 | 0.220 |
Why?
|
Intelligence | 3 | 2008 | 924 | 0.220 |
Why?
|
Transients and Migrants | 1 | 2006 | 162 | 0.220 |
Why?
|
Carcinogens | 3 | 1998 | 451 | 0.210 |
Why?
|
Neoplasms, Experimental | 4 | 1998 | 1228 | 0.210 |
Why?
|
Occupational Diseases | 7 | 2010 | 1490 | 0.210 |
Why?
|
Phthalic Acids | 5 | 2006 | 478 | 0.210 |
Why?
|
Long-Term Care | 1 | 2007 | 633 | 0.210 |
Why?
|
Australia | 3 | 2017 | 1245 | 0.210 |
Why?
|
Longitudinal Studies | 18 | 2021 | 14565 | 0.210 |
Why?
|
Social Class | 3 | 2008 | 2003 | 0.200 |
Why?
|
Male | 123 | 2019 | 360035 | 0.200 |
Why?
|
Asthma | 14 | 2013 | 6195 | 0.200 |
Why?
|
Risk Assessment | 17 | 2014 | 23953 | 0.200 |
Why?
|
Pesticides | 6 | 2009 | 294 | 0.190 |
Why?
|
Population Surveillance | 4 | 2011 | 2603 | 0.190 |
Why?
|
Time Factors | 23 | 2022 | 39947 | 0.190 |
Why?
|
Reproduction | 3 | 2004 | 645 | 0.190 |
Why?
|
Vehicle Emissions | 3 | 2009 | 655 | 0.190 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1745 | 0.190 |
Why?
|
Congenital Abnormalities | 4 | 2007 | 706 | 0.190 |
Why?
|
Anticonvulsants | 6 | 2001 | 1903 | 0.190 |
Why?
|
Air Pollutants | 5 | 2009 | 2870 | 0.190 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2007 | 2204 | 0.180 |
Why?
|
Benchmarking | 2 | 2024 | 1045 | 0.180 |
Why?
|
Hospitalization | 3 | 2016 | 10698 | 0.180 |
Why?
|
Maternal Exposure | 7 | 2009 | 1058 | 0.180 |
Why?
|
Glutathione Transferase | 4 | 2007 | 565 | 0.180 |
Why?
|
Central Nervous System Depressants | 1 | 2021 | 164 | 0.180 |
Why?
|
Polychlorinated Biphenyls | 5 | 2009 | 235 | 0.180 |
Why?
|
Particulate Matter | 3 | 2010 | 2582 | 0.180 |
Why?
|
Adult | 97 | 2019 | 220781 | 0.170 |
Why?
|
Trauma Severity Indices | 2 | 2002 | 478 | 0.170 |
Why?
|
Patient Transfer | 1 | 2007 | 793 | 0.170 |
Why?
|
Hypersensitivity, Immediate | 3 | 2007 | 345 | 0.170 |
Why?
|
Ethylene Oxide | 1 | 1999 | 28 | 0.170 |
Why?
|
Sperm Motility | 8 | 2004 | 266 | 0.170 |
Why?
|
Semen | 4 | 2004 | 346 | 0.170 |
Why?
|
Abortion, Spontaneous | 5 | 2004 | 533 | 0.160 |
Why?
|
Allergens | 6 | 2008 | 1410 | 0.160 |
Why?
|
Air Pollution, Indoor | 6 | 2009 | 896 | 0.160 |
Why?
|
RNA, Ribosomal, 23S | 1 | 2018 | 54 | 0.160 |
Why?
|
Charophyceae | 1 | 2018 | 1 | 0.160 |
Why?
|
Trauma Centers | 2 | 2014 | 937 | 0.160 |
Why?
|
Sperm Count | 7 | 2004 | 229 | 0.150 |
Why?
|
Forecasting | 2 | 2022 | 2925 | 0.150 |
Why?
|
Epilepsy | 5 | 2001 | 3286 | 0.150 |
Why?
|
Software | 4 | 2019 | 4426 | 0.150 |
Why?
|
Water Pollution, Chemical | 3 | 2004 | 31 | 0.150 |
Why?
|
Water Supply | 7 | 2007 | 206 | 0.150 |
Why?
|
Multilocus Sequence Typing | 1 | 2018 | 100 | 0.150 |
Why?
|
Child | 32 | 2024 | 80086 | 0.150 |
Why?
|
Immunoglobulin E | 7 | 2006 | 1494 | 0.150 |
Why?
|
Epidemiologic Methods | 2 | 2009 | 1336 | 0.150 |
Why?
|
Disinfectants | 1 | 1999 | 129 | 0.150 |
Why?
|
Follow-Up Studies | 6 | 2017 | 39078 | 0.150 |
Why?
|
Ethanol | 2 | 2021 | 1324 | 0.150 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2019 | 305 | 0.150 |
Why?
|
Models, Biological | 5 | 2007 | 9462 | 0.150 |
Why?
|
Chemical Industry | 5 | 2001 | 116 | 0.150 |
Why?
|
Sunburn | 2 | 2010 | 156 | 0.150 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 282 | 0.140 |
Why?
|
Factor Analysis, Statistical | 2 | 1999 | 999 | 0.140 |
Why?
|
Water Pollutants, Chemical | 3 | 2006 | 356 | 0.140 |
Why?
|
Middle Aged | 55 | 2019 | 220382 | 0.140 |
Why?
|
Glycosyltransferases | 1 | 2018 | 117 | 0.140 |
Why?
|
Cohort Studies | 30 | 2019 | 41366 | 0.140 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 1996 | 25 | 0.140 |
Why?
|
Molecular Epidemiology | 2 | 2018 | 468 | 0.140 |
Why?
|
Benzene | 4 | 2000 | 106 | 0.140 |
Why?
|
Kidney Diseases | 3 | 2019 | 2093 | 0.140 |
Why?
|
Aged | 40 | 2019 | 168840 | 0.140 |
Why?
|
Dust | 4 | 2008 | 487 | 0.140 |
Why?
|
Receptors, Cell Surface | 4 | 2019 | 2819 | 0.140 |
Why?
|
Risk Factors | 41 | 2017 | 74055 | 0.140 |
Why?
|
Lead | 3 | 2008 | 879 | 0.130 |
Why?
|
China | 18 | 2005 | 2339 | 0.130 |
Why?
|
Patient Admission | 2 | 2002 | 1367 | 0.130 |
Why?
|
Age Distribution | 4 | 2016 | 2878 | 0.130 |
Why?
|
Sarcoma | 8 | 2003 | 1791 | 0.130 |
Why?
|
Queensland | 2 | 2016 | 52 | 0.130 |
Why?
|
Arsenic Poisoning | 2 | 2007 | 55 | 0.130 |
Why?
|
Proportional Hazards Models | 9 | 2002 | 12429 | 0.130 |
Why?
|
Epidemiologic Research Design | 2 | 2010 | 368 | 0.130 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 225 | 0.130 |
Why?
|
Poisson Distribution | 3 | 2010 | 504 | 0.130 |
Why?
|
Cluster Analysis | 3 | 2017 | 2711 | 0.130 |
Why?
|
Hospital Mortality | 3 | 2014 | 5283 | 0.130 |
Why?
|
Risk | 3 | 2010 | 9605 | 0.120 |
Why?
|
Methylmercury Compounds | 2 | 2008 | 102 | 0.120 |
Why?
|
Pregnancy Complications | 5 | 2001 | 2946 | 0.120 |
Why?
|
Ozone | 2 | 1996 | 482 | 0.120 |
Why?
|
Community Health Services | 1 | 2000 | 656 | 0.120 |
Why?
|
Body Weight | 3 | 2018 | 4614 | 0.120 |
Why?
|
Polymorphism, Genetic | 6 | 2007 | 4287 | 0.120 |
Why?
|
Analysis of Variance | 5 | 2018 | 6230 | 0.120 |
Why?
|
Child, Preschool | 22 | 2018 | 42209 | 0.120 |
Why?
|
Fertilization in Vitro | 2 | 2013 | 1292 | 0.120 |
Why?
|
Automobile Driving | 3 | 2004 | 440 | 0.120 |
Why?
|
Fingers | 3 | 2003 | 506 | 0.120 |
Why?
|
Observer Variation | 3 | 2015 | 2604 | 0.120 |
Why?
|
DNA Damage | 4 | 2006 | 2441 | 0.120 |
Why?
|
Injury Severity Score | 3 | 2014 | 1045 | 0.120 |
Why?
|
Respiratory Tract Infections | 5 | 2006 | 1010 | 0.120 |
Why?
|
Fetus | 2 | 1999 | 1863 | 0.110 |
Why?
|
Skin Diseases | 3 | 2007 | 1090 | 0.110 |
Why?
|
Emigration and Immigration | 2 | 2007 | 396 | 0.110 |
Why?
|
Infant, Newborn | 25 | 2015 | 26280 | 0.110 |
Why?
|
Diethylhexyl Phthalate | 2 | 2006 | 83 | 0.110 |
Why?
|
Epigenesis, Genetic | 1 | 2007 | 3782 | 0.110 |
Why?
|
Interleukin-13 | 2 | 2006 | 375 | 0.110 |
Why?
|
Socioeconomic Factors | 4 | 2016 | 7817 | 0.110 |
Why?
|
Depressive Disorder | 1 | 2006 | 3728 | 0.110 |
Why?
|
Patient Discharge | 2 | 2007 | 3436 | 0.110 |
Why?
|
Cognition | 4 | 2021 | 6973 | 0.110 |
Why?
|
Taiwan | 8 | 2010 | 515 | 0.110 |
Why?
|
Pulmonary Fibrosis | 2 | 1995 | 505 | 0.110 |
Why?
|
Chorionic Gonadotropin | 3 | 2005 | 457 | 0.110 |
Why?
|
DNA Methylation | 1 | 2007 | 4383 | 0.100 |
Why?
|
Executive Function | 1 | 2021 | 1383 | 0.100 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 2 | 2003 | 85 | 0.100 |
Why?
|
Heart Injuries | 1 | 2014 | 205 | 0.100 |
Why?
|
Sample Size | 1 | 2016 | 839 | 0.100 |
Why?
|
Algorithms | 9 | 2024 | 14002 | 0.100 |
Why?
|
Follicle Stimulating Hormone | 3 | 2006 | 726 | 0.100 |
Why?
|
Rhinitis | 2 | 2002 | 746 | 0.100 |
Why?
|
Adolescent | 27 | 2018 | 88196 | 0.100 |
Why?
|
Emergency Service, Hospital | 1 | 2011 | 7860 | 0.100 |
Why?
|
Vibration | 2 | 2004 | 328 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 1 | 2018 | 1952 | 0.100 |
Why?
|
Comet Assay | 4 | 2006 | 72 | 0.100 |
Why?
|
Fungi | 2 | 2005 | 338 | 0.100 |
Why?
|
Luteinizing Hormone | 3 | 2006 | 820 | 0.100 |
Why?
|
Child Day Care Centers | 2 | 2002 | 122 | 0.090 |
Why?
|
Carbaryl | 3 | 2005 | 8 | 0.090 |
Why?
|
Skin Neoplasms | 5 | 2010 | 5815 | 0.090 |
Why?
|
Problem Solving | 1 | 2014 | 441 | 0.090 |
Why?
|
Chlorpyrifos | 3 | 2005 | 19 | 0.090 |
Why?
|
Sex Distribution | 1 | 2016 | 2281 | 0.090 |
Why?
|
Genes, p53 | 2 | 2004 | 712 | 0.090 |
Why?
|
Pregnancy Outcome | 6 | 2006 | 2916 | 0.090 |
Why?
|
Rats, Inbred F344 | 3 | 1996 | 825 | 0.090 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11453 | 0.090 |
Why?
|
Phylogeny | 1 | 2018 | 2806 | 0.090 |
Why?
|
Troponin | 1 | 2014 | 501 | 0.090 |
Why?
|
Arsenicals | 3 | 2008 | 118 | 0.090 |
Why?
|
Stress, Psychological | 4 | 2010 | 4475 | 0.090 |
Why?
|
Phosphonoacetic Acid | 2 | 2001 | 54 | 0.090 |
Why?
|
Troponin I | 1 | 2014 | 635 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 2014 | 412 | 0.090 |
Why?
|
Glutathione S-Transferase pi | 2 | 2007 | 99 | 0.090 |
Why?
|
Cause of Death | 3 | 2010 | 3686 | 0.090 |
Why?
|
Aspartic Acid | 3 | 2007 | 576 | 0.090 |
Why?
|
Eczema | 2 | 2002 | 245 | 0.090 |
Why?
|
Infant | 20 | 2015 | 36183 | 0.080 |
Why?
|
Monte Carlo Method | 4 | 2005 | 1257 | 0.080 |
Why?
|
Airway Obstruction | 1 | 1995 | 661 | 0.080 |
Why?
|
Housing | 2 | 2005 | 667 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 7 | 2016 | 17854 | 0.080 |
Why?
|
Toxicity Tests | 2 | 2000 | 114 | 0.080 |
Why?
|
Fetal Blood | 2 | 2006 | 1346 | 0.080 |
Why?
|
Boston | 11 | 2008 | 9326 | 0.080 |
Why?
|
Confidence Intervals | 5 | 2002 | 2927 | 0.080 |
Why?
|
Incineration | 1 | 2009 | 21 | 0.080 |
Why?
|
Petroleum | 2 | 2000 | 80 | 0.080 |
Why?
|
Residence Characteristics | 3 | 2009 | 2087 | 0.080 |
Why?
|
Lactic Acid | 1 | 2014 | 1134 | 0.080 |
Why?
|
Odds Ratio | 10 | 2013 | 9639 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7424 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2000 | 2852 | 0.080 |
Why?
|
Poverty | 4 | 2009 | 2694 | 0.080 |
Why?
|
Gestational Age | 3 | 2004 | 3574 | 0.080 |
Why?
|
Ectromelia | 1 | 2009 | 28 | 0.080 |
Why?
|
Alleles | 3 | 2018 | 6908 | 0.080 |
Why?
|
Follicular Fluid | 1 | 2009 | 92 | 0.080 |
Why?
|
Infertility, Male | 4 | 2006 | 396 | 0.080 |
Why?
|
Biostatistics | 1 | 2010 | 164 | 0.080 |
Why?
|
Depression | 6 | 2010 | 8104 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 2 | 2005 | 812 | 0.080 |
Why?
|
Naphthols | 2 | 2006 | 46 | 0.080 |
Why?
|
Forced Expiratory Volume | 1 | 2013 | 1812 | 0.080 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2009 | 120 | 0.080 |
Why?
|
Inhibins | 2 | 2006 | 209 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 4000 | 0.080 |
Why?
|
Pneumonia, Bacterial | 1 | 2011 | 316 | 0.080 |
Why?
|
Sunlight | 1 | 2010 | 337 | 0.070 |
Why?
|
Crime | 1 | 2009 | 202 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 2014 | 807 | 0.070 |
Why?
|
Air Pollutants, Occupational | 1 | 2010 | 407 | 0.070 |
Why?
|
Genes, Homeobox | 1 | 2009 | 285 | 0.070 |
Why?
|
Cats | 3 | 2005 | 975 | 0.070 |
Why?
|
Self-Injurious Behavior | 1 | 2014 | 565 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2010 | 461 | 0.070 |
Why?
|
Menstrual Cycle | 2 | 2001 | 539 | 0.070 |
Why?
|
Animals | 29 | 2009 | 168253 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 1998 | 11729 | 0.070 |
Why?
|
Antigens, Dermatophagoides | 1 | 2007 | 97 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2007 | 106 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2004 | 779 | 0.070 |
Why?
|
Albuminuria | 2 | 2001 | 650 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2000 | 10180 | 0.070 |
Why?
|
Geographic Information Systems | 1 | 2009 | 281 | 0.070 |
Why?
|
Clinical Trials as Topic | 5 | 1996 | 7996 | 0.070 |
Why?
|
Survival Rate | 8 | 2010 | 12698 | 0.070 |
Why?
|
Parathion | 3 | 2000 | 14 | 0.070 |
Why?
|
Areca | 1 | 2006 | 11 | 0.070 |
Why?
|
Organothiophosphorus Compounds | 3 | 2000 | 14 | 0.070 |
Why?
|
Inhalation Exposure | 1 | 2009 | 430 | 0.070 |
Why?
|
Smoking | 10 | 2006 | 9046 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2003 | 643 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 3202 | 0.070 |
Why?
|
London | 1 | 2006 | 234 | 0.070 |
Why?
|
Genes, Dominant | 1 | 2009 | 862 | 0.070 |
Why?
|
Hypersensitivity | 2 | 2005 | 1157 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 5 | 1993 | 1154 | 0.060 |
Why?
|
Tretinoin | 1 | 2009 | 519 | 0.060 |
Why?
|
Ifosfamide | 6 | 1993 | 232 | 0.060 |
Why?
|
Pregnanediol | 1 | 2005 | 18 | 0.060 |
Why?
|
Seasons | 1 | 2011 | 1518 | 0.060 |
Why?
|
Aged, 80 and over | 12 | 2016 | 58859 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2014 | 1715 | 0.060 |
Why?
|
Fluorouracil | 3 | 2001 | 1637 | 0.060 |
Why?
|
Birth Weight | 6 | 2006 | 2098 | 0.060 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2005 | 59 | 0.060 |
Why?
|
Carbon Monoxide | 1 | 2009 | 543 | 0.060 |
Why?
|
Esophageal Neoplasms | 4 | 1998 | 1646 | 0.060 |
Why?
|
Estrogen Receptor Modulators | 1 | 2005 | 58 | 0.060 |
Why?
|
Mobility Limitation | 1 | 2009 | 408 | 0.060 |
Why?
|
Infant, Low Birth Weight | 2 | 2002 | 868 | 0.060 |
Why?
|
Fetal Growth Retardation | 2 | 2001 | 579 | 0.060 |
Why?
|
Organic Chemicals | 2 | 2004 | 211 | 0.060 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2009 | 497 | 0.060 |
Why?
|
Alcohol Drinking | 6 | 2024 | 4026 | 0.060 |
Why?
|
Sex Factors | 6 | 2007 | 10538 | 0.060 |
Why?
|
Respiration Disorders | 1 | 2007 | 367 | 0.060 |
Why?
|
Oligomenorrhea | 2 | 2001 | 42 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1150 | 0.060 |
Why?
|
Research Design | 6 | 2015 | 6168 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2010 | 4020 | 0.060 |
Why?
|
Motor Vehicles | 1 | 2006 | 282 | 0.060 |
Why?
|
Incidence | 8 | 2014 | 21322 | 0.060 |
Why?
|
Particle Size | 3 | 2009 | 1643 | 0.060 |
Why?
|
Fetal Death | 3 | 1999 | 435 | 0.060 |
Why?
|
Mercury | 1 | 2007 | 288 | 0.060 |
Why?
|
Mercury Poisoning | 1 | 2004 | 32 | 0.060 |
Why?
|
Estrone | 1 | 2005 | 234 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 1999 | 1156 | 0.060 |
Why?
|
Herbicides | 1 | 2004 | 105 | 0.060 |
Why?
|
Mothers | 2 | 2006 | 2191 | 0.060 |
Why?
|
Young Adult | 6 | 2018 | 59068 | 0.060 |
Why?
|
Child Behavior | 3 | 2021 | 847 | 0.050 |
Why?
|
Self Efficacy | 1 | 2007 | 635 | 0.050 |
Why?
|
Registries | 2 | 2016 | 8216 | 0.050 |
Why?
|
Hydrocarbons | 1 | 2004 | 105 | 0.050 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2006 | 548 | 0.050 |
Why?
|
Interferon-alpha | 2 | 2001 | 920 | 0.050 |
Why?
|
Mesna | 4 | 1990 | 62 | 0.050 |
Why?
|
Comorbidity | 2 | 2016 | 10494 | 0.050 |
Why?
|
Uncertainty | 1 | 2008 | 753 | 0.050 |
Why?
|
Aldehydes | 1 | 2004 | 170 | 0.050 |
Why?
|
Follicular Phase | 1 | 2003 | 143 | 0.050 |
Why?
|
Pyridones | 2 | 2006 | 807 | 0.050 |
Why?
|
Mice | 11 | 2009 | 81402 | 0.050 |
Why?
|
Food Contamination | 1 | 2004 | 191 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1737 | 0.050 |
Why?
|
Alcohol Dehydrogenase | 1 | 2002 | 111 | 0.050 |
Why?
|
Urban Health | 3 | 2004 | 533 | 0.050 |
Why?
|
Infant Food | 1 | 2002 | 140 | 0.050 |
Why?
|
Maine | 1 | 2002 | 147 | 0.050 |
Why?
|
Humidity | 1 | 2003 | 205 | 0.050 |
Why?
|
Psychometrics | 2 | 2008 | 3063 | 0.050 |
Why?
|
DDT | 1 | 2001 | 31 | 0.050 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2002 | 119 | 0.050 |
Why?
|
Membrane Glycoproteins | 3 | 2005 | 3701 | 0.050 |
Why?
|
Cost of Illness | 1 | 2011 | 1931 | 0.050 |
Why?
|
Testosterone | 2 | 2006 | 2471 | 0.050 |
Why?
|
Cross Infection | 1 | 2011 | 1438 | 0.050 |
Why?
|
Rats | 5 | 1996 | 23712 | 0.050 |
Why?
|
Critical Care | 1 | 2014 | 2697 | 0.050 |
Why?
|
Massachusetts | 5 | 2013 | 8826 | 0.050 |
Why?
|
Parenting | 1 | 2007 | 698 | 0.050 |
Why?
|
Benzene Derivatives | 1 | 2001 | 53 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2014 | 5105 | 0.050 |
Why?
|
Fathers | 1 | 2004 | 376 | 0.050 |
Why?
|
Mitoxantrone | 2 | 1999 | 148 | 0.050 |
Why?
|
Electrocardiography | 1 | 2014 | 6380 | 0.050 |
Why?
|
Drosophila Proteins | 2 | 2001 | 1698 | 0.050 |
Why?
|
Monocytes | 2 | 2001 | 2572 | 0.050 |
Why?
|
Solvents | 1 | 2002 | 294 | 0.050 |
Why?
|
Dermatitis, Atopic | 1 | 2008 | 716 | 0.050 |
Why?
|
Bangladesh | 3 | 2008 | 731 | 0.050 |
Why?
|
Hormones | 1 | 2004 | 867 | 0.050 |
Why?
|
Seafood | 1 | 2004 | 391 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2215 | 0.040 |
Why?
|
Air Pollution | 2 | 2009 | 2342 | 0.040 |
Why?
|
Phenytoin | 1 | 2001 | 189 | 0.040 |
Why?
|
Hypophosphatasia | 2 | 1995 | 11 | 0.040 |
Why?
|
Drug Evaluation | 6 | 1992 | 642 | 0.040 |
Why?
|
Phenobarbital | 1 | 2001 | 191 | 0.040 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20078 | 0.040 |
Why?
|
Prospective Studies | 14 | 2021 | 54339 | 0.040 |
Why?
|
Aclarubicin | 1 | 1999 | 12 | 0.040 |
Why?
|
Intelligence Tests | 1 | 2021 | 503 | 0.040 |
Why?
|
Carbamazepine | 1 | 2001 | 224 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2002 | 580 | 0.040 |
Why?
|
Binomial Distribution | 1 | 1999 | 23 | 0.040 |
Why?
|
Predictive Value of Tests | 5 | 2014 | 15257 | 0.040 |
Why?
|
Women's Health | 2 | 2007 | 2065 | 0.040 |
Why?
|
Antineoplastic Agents | 6 | 2001 | 13616 | 0.040 |
Why?
|
Obstetric Labor, Premature | 1 | 2001 | 272 | 0.040 |
Why?
|
Spiro Compounds | 1 | 1999 | 68 | 0.040 |
Why?
|
Esterases | 1 | 1999 | 98 | 0.040 |
Why?
|
Lung Neoplasms | 4 | 2015 | 13312 | 0.040 |
Why?
|
Urban Population | 5 | 2007 | 2032 | 0.040 |
Why?
|
Menstruation Disturbances | 1 | 2000 | 143 | 0.040 |
Why?
|
Transportation | 1 | 2001 | 216 | 0.040 |
Why?
|
Lymphoid Tissue | 1 | 2001 | 445 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2003 | 495 | 0.040 |
Why?
|
Leucovorin | 1 | 2001 | 642 | 0.040 |
Why?
|
Risk-Taking | 2 | 2008 | 1036 | 0.040 |
Why?
|
Bone Resorption | 1 | 2003 | 723 | 0.040 |
Why?
|
Family | 1 | 2010 | 3189 | 0.040 |
Why?
|
Granulocytes | 1 | 2001 | 550 | 0.040 |
Why?
|
Stomach Neoplasms | 2 | 1999 | 1428 | 0.040 |
Why?
|
Mathematical Computing | 1 | 1999 | 142 | 0.040 |
Why?
|
Melanoma | 2 | 1998 | 5704 | 0.040 |
Why?
|
United States | 13 | 2011 | 72202 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2003 | 874 | 0.040 |
Why?
|
Xylans | 1 | 2018 | 8 | 0.040 |
Why?
|
Cities | 1 | 2001 | 543 | 0.040 |
Why?
|
Neoplasms | 4 | 2016 | 22083 | 0.040 |
Why?
|
Cardiovascular Abnormalities | 1 | 1999 | 143 | 0.040 |
Why?
|
Valproic Acid | 1 | 2001 | 442 | 0.040 |
Why?
|
Cobalt Radioisotopes | 1 | 1998 | 75 | 0.040 |
Why?
|
Etoposide | 1 | 1999 | 634 | 0.040 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2000 | 412 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 2000 | 337 | 0.040 |
Why?
|
Pectins | 1 | 2018 | 27 | 0.040 |
Why?
|
Eye Enucleation | 1 | 1998 | 128 | 0.040 |
Why?
|
Growth Charts | 1 | 2018 | 60 | 0.040 |
Why?
|
Glucans | 1 | 2018 | 68 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2000 | 250 | 0.040 |
Why?
|
Fatty Acids | 1 | 2006 | 1805 | 0.040 |
Why?
|
Lymphocytes | 1 | 2006 | 2610 | 0.040 |
Why?
|
Rural Health | 1 | 1999 | 296 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 3076 | 0.040 |
Why?
|
Preventive Medicine | 1 | 1999 | 246 | 0.040 |
Why?
|
Doxorubicin | 6 | 1998 | 2215 | 0.040 |
Why?
|
Statistics as Topic | 2 | 1999 | 2357 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2008 | 1540 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3609 | 0.040 |
Why?
|
Research | 1 | 2006 | 1977 | 0.040 |
Why?
|
Diet, Fat-Restricted | 1 | 2000 | 329 | 0.040 |
Why?
|
Methylation | 3 | 2006 | 1082 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14661 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3157 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2009 | 1847 | 0.040 |
Why?
|
Infertility, Female | 2 | 1993 | 758 | 0.040 |
Why?
|
Prognosis | 7 | 2014 | 29551 | 0.040 |
Why?
|
Diet | 3 | 2006 | 8058 | 0.030 |
Why?
|
BCG Vaccine | 1 | 2000 | 369 | 0.030 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 1977 | 58 | 0.030 |
Why?
|
Alkaline Phosphatase | 2 | 1995 | 866 | 0.030 |
Why?
|
Proteinuria | 1 | 2000 | 600 | 0.030 |
Why?
|
Cryopreservation | 1 | 2002 | 725 | 0.030 |
Why?
|
Respiratory Function Tests | 2 | 2007 | 1681 | 0.030 |
Why?
|
Choroid Neoplasms | 1 | 1998 | 177 | 0.030 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2019 | 288 | 0.030 |
Why?
|
Age Factors | 5 | 2009 | 18379 | 0.030 |
Why?
|
Propylene Glycols | 1 | 1996 | 91 | 0.030 |
Why?
|
Social Support | 1 | 2006 | 2167 | 0.030 |
Why?
|
Genotype | 4 | 2007 | 12976 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2018 | 1792 | 0.030 |
Why?
|
Poverty Areas | 2 | 2007 | 264 | 0.030 |
Why?
|
Cisplatin | 4 | 1996 | 1647 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1999 | 649 | 0.030 |
Why?
|
Seychelles | 2 | 2007 | 5 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2001 | 3439 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2006 | 6019 | 0.030 |
Why?
|
Zidovudine | 1 | 1998 | 624 | 0.030 |
Why?
|
Public Health | 3 | 2004 | 2665 | 0.030 |
Why?
|
Hyperglycemia | 2 | 2001 | 1371 | 0.030 |
Why?
|
Flame Retardants | 1 | 1996 | 96 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 12127 | 0.030 |
Why?
|
Aneuploidy | 1 | 1999 | 551 | 0.030 |
Why?
|
Textile Industry | 3 | 2000 | 74 | 0.030 |
Why?
|
Cacodylic Acid | 2 | 2006 | 14 | 0.030 |
Why?
|
Mental Health | 1 | 2010 | 3241 | 0.030 |
Why?
|
Health Status | 1 | 2008 | 4071 | 0.030 |
Why?
|
Data Collection | 4 | 2004 | 3321 | 0.030 |
Why?
|
Skin Tests | 2 | 2008 | 637 | 0.030 |
Why?
|
Knee Joint | 1 | 2004 | 1673 | 0.030 |
Why?
|
Fluorescence | 1 | 2018 | 756 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2002 | 816 | 0.030 |
Why?
|
Anthropometry | 1 | 2000 | 1349 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2004 | 1508 | 0.030 |
Why?
|
Face | 1 | 2001 | 1020 | 0.030 |
Why?
|
Isoniazid | 1 | 1996 | 283 | 0.030 |
Why?
|
Glycosylation | 1 | 2018 | 1097 | 0.030 |
Why?
|
Cell Wall | 1 | 2018 | 425 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2003 | 1896 | 0.030 |
Why?
|
Toll-Like Receptors | 3 | 2005 | 589 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8689 | 0.030 |
Why?
|
Prenatal Diagnosis | 2 | 1999 | 1265 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2010 | 15476 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5491 | 0.030 |
Why?
|
Reference Values | 3 | 2003 | 4921 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2000 | 1035 | 0.030 |
Why?
|
Decision Making | 1 | 2008 | 3923 | 0.030 |
Why?
|
Radiotherapy | 1 | 2000 | 1498 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 30025 | 0.030 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2013 | 88 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2014 | 80430 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2509 | 0.030 |
Why?
|
Respiratory System | 1 | 1996 | 563 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2000 | 1422 | 0.030 |
Why?
|
Trimetrexate | 1 | 1992 | 15 | 0.030 |
Why?
|
Brazil | 2 | 2007 | 1224 | 0.030 |
Why?
|
Actuarial Analysis | 2 | 1989 | 374 | 0.030 |
Why?
|
Anxiety | 1 | 2007 | 4558 | 0.030 |
Why?
|
Colorectal Neoplasms | 3 | 2001 | 6894 | 0.030 |
Why?
|
Drug Administration Schedule | 5 | 1993 | 4849 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15867 | 0.030 |
Why?
|
Rodentia | 1 | 1994 | 261 | 0.030 |
Why?
|
Ovulation | 1 | 1993 | 181 | 0.030 |
Why?
|
Thinness | 2 | 2007 | 490 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2013 | 237 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2000 | 2205 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2000 | 1050 | 0.020 |
Why?
|
Dietary Fats | 1 | 2000 | 1994 | 0.020 |
Why?
|
Random Allocation | 3 | 2000 | 2388 | 0.020 |
Why?
|
Codon | 2 | 2004 | 602 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3800 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 1999 | 6330 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 1995 | 415 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2003 | 2572 | 0.020 |
Why?
|
Polysaccharides | 1 | 2018 | 1014 | 0.020 |
Why?
|
Body Mass Index | 3 | 2004 | 12932 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3571 | 0.020 |
Why?
|
Attention | 1 | 2021 | 2391 | 0.020 |
Why?
|
Thiadiazoles | 1 | 1991 | 64 | 0.020 |
Why?
|
Interferon-beta | 1 | 1992 | 345 | 0.020 |
Why?
|
Glutamine | 2 | 2007 | 576 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 1999 | 1186 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2008 | 4569 | 0.020 |
Why?
|
Databases, Factual | 3 | 2015 | 7948 | 0.020 |
Why?
|
Mesothelioma | 1 | 1996 | 807 | 0.020 |
Why?
|
Isoenzymes | 1 | 1995 | 1688 | 0.020 |
Why?
|
Maternal Age | 2 | 2006 | 809 | 0.020 |
Why?
|
Nausea | 1 | 1993 | 679 | 0.020 |
Why?
|
Single-Blind Method | 3 | 2000 | 1571 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2123 | 0.020 |
Why?
|
Fetal Mortality | 1 | 2009 | 19 | 0.020 |
Why?
|
Cystitis | 1 | 1990 | 95 | 0.020 |
Why?
|
Methyl Parathion | 2 | 1999 | 7 | 0.020 |
Why?
|
Cross-Sectional Studies | 7 | 2006 | 26063 | 0.020 |
Why?
|
Treatment Outcome | 8 | 2014 | 64591 | 0.020 |
Why?
|
Liver Neoplasms | 2 | 2000 | 4319 | 0.020 |
Why?
|
Rural Population | 1 | 2000 | 2279 | 0.020 |
Why?
|
Interviews as Topic | 2 | 2007 | 2683 | 0.020 |
Why?
|
Mercaptoethanol | 1 | 1989 | 63 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 2199 | 0.020 |
Why?
|
Hodgkin Disease | 1 | 1996 | 1378 | 0.020 |
Why?
|
Pain | 1 | 2004 | 5075 | 0.020 |
Why?
|
Fresh Water | 1 | 2008 | 82 | 0.020 |
Why?
|
Connecticut | 1 | 2009 | 364 | 0.020 |
Why?
|
Prevalence | 5 | 2005 | 15698 | 0.020 |
Why?
|
Caffeine | 1 | 1993 | 700 | 0.020 |
Why?
|
Workplace | 1 | 2015 | 863 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2009 | 162 | 0.020 |
Why?
|
Power Plants | 1 | 2009 | 123 | 0.020 |
Why?
|
Probability | 2 | 2002 | 2476 | 0.020 |
Why?
|
Guatemala | 1 | 2009 | 159 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 2 | 2001 | 344 | 0.020 |
Why?
|
Colony-Stimulating Factors | 1 | 1988 | 218 | 0.020 |
Why?
|
Infusions, Intravenous | 3 | 2001 | 2217 | 0.020 |
Why?
|
Dietary Fiber | 2 | 2004 | 759 | 0.020 |
Why?
|
Leukopenia | 1 | 1988 | 213 | 0.020 |
Why?
|
Creatinine | 2 | 2005 | 1898 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2000 | 2529 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2009 | 915 | 0.020 |
Why?
|
Workload | 2 | 2004 | 844 | 0.020 |
Why?
|
Hematuria | 1 | 1989 | 233 | 0.020 |
Why?
|
Arsenates | 1 | 2006 | 10 | 0.020 |
Why?
|
Self Disclosure | 2 | 2002 | 249 | 0.020 |
Why?
|
Stress Disorders, Traumatic | 1 | 2007 | 50 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 1998 | 2821 | 0.020 |
Why?
|
Asparagine | 1 | 2007 | 119 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2007 | 314 | 0.020 |
Why?
|
Hemophilia A | 2 | 2002 | 360 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 468 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 7029 | 0.020 |
Why?
|
Arsenites | 1 | 2006 | 65 | 0.020 |
Why?
|
Cooking | 1 | 2009 | 312 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 22121 | 0.020 |
Why?
|
Body Burden | 1 | 2007 | 158 | 0.020 |
Why?
|
Motor Skills Disorders | 1 | 2007 | 89 | 0.020 |
Why?
|
Birth Rate | 1 | 2007 | 168 | 0.020 |
Why?
|
Collagen | 1 | 1995 | 2637 | 0.020 |
Why?
|
Nitrogen Dioxide | 1 | 2009 | 520 | 0.020 |
Why?
|
Growth Substances | 1 | 1988 | 768 | 0.020 |
Why?
|
Limulus Test | 1 | 2005 | 19 | 0.020 |
Why?
|
Weight Gain | 1 | 1996 | 2346 | 0.020 |
Why?
|
New Zealand | 1 | 2007 | 357 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4369 | 0.020 |
Why?
|
Soil Pollutants | 1 | 2006 | 73 | 0.020 |
Why?
|
Spouse Abuse | 1 | 2007 | 182 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1990 | 496 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1248 | 0.020 |
Why?
|
United States Department of Veterans Affairs | 1 | 2011 | 923 | 0.020 |
Why?
|
Markov Chains | 1 | 1989 | 965 | 0.020 |
Why?
|
England | 1 | 2007 | 527 | 0.020 |
Why?
|
Fabaceae | 1 | 2006 | 103 | 0.020 |
Why?
|
Psychopathology | 1 | 2008 | 431 | 0.020 |
Why?
|
DNA | 1 | 1999 | 7208 | 0.020 |
Why?
|
Breast Neoplasms | 4 | 2002 | 20985 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2010 | 760 | 0.020 |
Why?
|
Rabbits | 1 | 1991 | 4780 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1987 | 1627 | 0.020 |
Why?
|
Sperm Tail | 1 | 2004 | 15 | 0.020 |
Why?
|
Tobacco, Smokeless | 1 | 2006 | 133 | 0.020 |
Why?
|
Nails | 1 | 2006 | 295 | 0.010 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2006 | 226 | 0.010 |
Why?
|
New England | 1 | 2007 | 1052 | 0.010 |
Why?
|
Bone and Bones | 2 | 2008 | 2566 | 0.010 |
Why?
|
Crime Victims | 1 | 2008 | 347 | 0.010 |
Why?
|
Body Patterning | 1 | 2009 | 632 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2723 | 0.010 |
Why?
|
Volatilization | 1 | 2004 | 77 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 2004 | 151 | 0.010 |
Why?
|
Endpoint Determination | 1 | 2007 | 590 | 0.010 |
Why?
|
Gram-Negative Bacteria | 1 | 2005 | 272 | 0.010 |
Why?
|
Naphthalenes | 1 | 2004 | 198 | 0.010 |
Why?
|
Fungal Structures | 1 | 2003 | 2 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 661 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1989 | 1438 | 0.010 |
Why?
|
Administration, Oral | 2 | 2002 | 4010 | 0.010 |
Why?
|
Mitomycins | 2 | 1993 | 46 | 0.010 |
Why?
|
Disease-Free Survival | 3 | 2000 | 6813 | 0.010 |
Why?
|
Foot Deformities, Congenital | 1 | 2003 | 59 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 674 | 0.010 |
Why?
|
Health Behavior | 2 | 2008 | 2637 | 0.010 |
Why?
|
Infant Equipment | 1 | 2002 | 23 | 0.010 |
Why?
|
Animals, Domestic | 1 | 2002 | 57 | 0.010 |
Why?
|
Urinalysis | 1 | 2005 | 368 | 0.010 |
Why?
|
Sampling Studies | 1 | 2004 | 615 | 0.010 |
Why?
|
Acceleration | 1 | 2003 | 189 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 665 | 0.010 |
Why?
|
Immunoradiometric Assay | 1 | 2002 | 20 | 0.010 |
Why?
|
Perception | 1 | 2009 | 1196 | 0.010 |
Why?
|
Air Microbiology | 1 | 2003 | 95 | 0.010 |
Why?
|
Wounds, Gunshot | 1 | 2008 | 582 | 0.010 |
Why?
|
Osteitis Deformans | 1 | 1982 | 54 | 0.010 |
Why?
|
Absenteeism | 1 | 2004 | 247 | 0.010 |
Why?
|
Lysine | 1 | 2007 | 992 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1993 | 4903 | 0.010 |
Why?
|
Mental Health Services | 1 | 2014 | 1730 | 0.010 |
Why?
|
Chi-Square Distribution | 2 | 2001 | 3418 | 0.010 |
Why?
|
Walking | 1 | 2009 | 1199 | 0.010 |
Why?
|
Spine | 1 | 2009 | 1118 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 786 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 2001 | 82 | 0.010 |
Why?
|
HIV Infections | 3 | 2003 | 17328 | 0.010 |
Why?
|
Factor VII | 1 | 2002 | 139 | 0.010 |
Why?
|
Placental Circulation | 1 | 2001 | 37 | 0.010 |
Why?
|
Critical Illness | 1 | 2014 | 2722 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2189 | 0.010 |
Why?
|
Mexico | 1 | 2004 | 761 | 0.010 |
Why?
|
Teratology | 1 | 2000 | 8 | 0.010 |
Why?
|
Recombinant Proteins | 3 | 2001 | 6525 | 0.010 |
Why?
|
Victoria | 1 | 2000 | 64 | 0.010 |
Why?
|
Death | 1 | 1985 | 676 | 0.010 |
Why?
|
Brain Diseases | 1 | 1990 | 1544 | 0.010 |
Why?
|
Nitrogen | 1 | 2002 | 348 | 0.010 |
Why?
|
Causality | 1 | 2007 | 1243 | 0.010 |
Why?
|
Heterozygote | 2 | 1999 | 2798 | 0.010 |
Why?
|
Organ Size | 1 | 2005 | 2252 | 0.010 |
Why?
|
Fruit | 1 | 2006 | 1160 | 0.010 |
Why?
|
Palatine Tonsil | 1 | 2001 | 193 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2002 | 882 | 0.010 |
Why?
|
Recurrence | 2 | 2002 | 8466 | 0.010 |
Why?
|
India | 1 | 2007 | 2341 | 0.010 |
Why?
|
Job Satisfaction | 1 | 2004 | 544 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 5359 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 2000 | 346 | 0.010 |
Why?
|
Satiation | 1 | 2000 | 83 | 0.010 |
Why?
|
Income | 1 | 2008 | 1874 | 0.010 |
Why?
|
Self Report | 1 | 2011 | 3721 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 365 | 0.010 |
Why?
|
Aryldialkylphosphatase | 1 | 1999 | 64 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2413 | 0.010 |
Why?
|
Fertility | 1 | 2004 | 771 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 115 | 0.010 |
Why?
|
Nitrophenols | 1 | 1999 | 169 | 0.010 |
Why?
|
Eye Abnormalities | 1 | 2001 | 241 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 708 | 0.010 |
Why?
|
Acetaldehyde | 1 | 1998 | 39 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1999 | 247 | 0.010 |
Why?
|
Community Health Centers | 1 | 2002 | 460 | 0.010 |
Why?
|
Pesticide Residues | 1 | 1999 | 95 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 1999 | 122 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1648 | 0.010 |
Why?
|
Semustine | 1 | 1998 | 11 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 1987 | 1157 | 0.010 |
Why?
|
Pilot Projects | 2 | 2002 | 8611 | 0.010 |
Why?
|
Y Chromosome | 1 | 1999 | 205 | 0.010 |
Why?
|
Preoperative Care | 1 | 1987 | 2242 | 0.010 |
Why?
|
Chlordan | 1 | 1997 | 5 | 0.010 |
Why?
|
Bone Marrow | 1 | 1988 | 2907 | 0.010 |
Why?
|
gamma-Glutamyltransferase | 1 | 1998 | 144 | 0.010 |
Why?
|
Autistic Disorder | 1 | 2007 | 1219 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2001 | 549 | 0.010 |
Why?
|
Erythrocyte Indices | 1 | 1998 | 144 | 0.010 |
Why?
|
Mitomycin | 1 | 1998 | 262 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3839 | 0.010 |
Why?
|
Streptozocin | 1 | 1998 | 193 | 0.010 |
Why?
|
Obesity | 1 | 2000 | 12918 | 0.010 |
Why?
|
Corneal Transplantation | 1 | 2001 | 321 | 0.010 |
Why?
|
Transferrin | 1 | 1998 | 284 | 0.010 |
Why?
|
Reproductive History | 1 | 1998 | 211 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5491 | 0.010 |
Why?
|
CHO Cells | 1 | 2000 | 1389 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2001 | 698 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1989 | 2525 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2000 | 552 | 0.010 |
Why?
|
Dacarbazine | 2 | 1990 | 559 | 0.010 |
Why?
|
Hydrogen Sulfide | 1 | 1998 | 141 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1998 | 363 | 0.010 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 350 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2006 | 1389 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1999 | 499 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2001 | 2004 | 0.010 |
Why?
|
Cricetinae | 1 | 2000 | 2427 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1999 | 677 | 0.010 |
Why?
|
X Chromosome | 1 | 1999 | 816 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 621 | 0.010 |
Why?
|
Quality Control | 1 | 1998 | 826 | 0.010 |
Why?
|
Arginine | 1 | 1999 | 933 | 0.010 |
Why?
|
Diphosphates | 1 | 1995 | 84 | 0.010 |
Why?
|
Pyridoxal Phosphate | 1 | 1995 | 125 | 0.010 |
Why?
|
Dietary Carbohydrates | 1 | 2000 | 891 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1987 | 2297 | 0.010 |
Why?
|
Low Back Pain | 1 | 2003 | 982 | 0.010 |
Why?
|
Esophagectomy | 1 | 1998 | 465 | 0.010 |
Why?
|
Infant, Premature | 1 | 2004 | 2104 | 0.010 |
Why?
|
Ethanolamines | 1 | 1995 | 152 | 0.010 |
Why?
|
Dietary Proteins | 1 | 2000 | 953 | 0.010 |
Why?
|
Medical History Taking | 1 | 1998 | 773 | 0.010 |
Why?
|
Homozygote | 1 | 1999 | 1794 | 0.010 |
Why?
|
Preventive Health Services | 1 | 1999 | 567 | 0.010 |
Why?
|
Breast Feeding | 1 | 2002 | 1357 | 0.010 |
Why?
|
Nurses | 1 | 2004 | 2471 | 0.010 |
Why?
|
Remission Induction | 2 | 1990 | 2394 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1996 | 1379 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4567 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7380 | 0.010 |
Why?
|
Fetal Resorption | 1 | 1993 | 15 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 2001 | 9176 | 0.010 |
Why?
|
Epitopes | 1 | 2000 | 2504 | 0.010 |
Why?
|
Abortion, Induced | 1 | 1999 | 462 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6086 | 0.010 |
Why?
|
Life Expectancy | 1 | 2000 | 1240 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 1999 | 960 | 0.010 |
Why?
|
Hot Temperature | 1 | 2000 | 1440 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1998 | 1784 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6128 | 0.010 |
Why?
|
Fallopian Tube Diseases | 1 | 1993 | 60 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2000 | 1400 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1998 | 8522 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2007 | 3975 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1999 | 1771 | 0.010 |
Why?
|
Head | 1 | 1998 | 924 | 0.010 |
Why?
|
Models, Chemical | 1 | 1994 | 611 | 0.010 |
Why?
|
Energy Intake | 1 | 2000 | 2134 | 0.010 |
Why?
|
Ethylene Glycols | 1 | 1993 | 190 | 0.010 |
Why?
|
Transfection | 1 | 2000 | 5776 | 0.010 |
Why?
|
Nonprescription Drugs | 1 | 1993 | 118 | 0.010 |
Why?
|
Treatment Failure | 1 | 1998 | 2642 | 0.010 |
Why?
|
Methyl Ethers | 1 | 1993 | 196 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1998 | 2898 | 0.010 |
Why?
|
Bone Marrow Diseases | 1 | 1993 | 232 | 0.010 |
Why?
|
NF-kappa B | 1 | 2000 | 2485 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1992 | 678 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1998 | 1185 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 1999 | 1755 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2000 | 6206 | 0.010 |
Why?
|
Syndrome | 1 | 1977 | 3267 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5865 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10425 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1998 | 3512 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2000 | 3209 | 0.010 |
Why?
|
Allopurinol | 1 | 1991 | 198 | 0.010 |
Why?
|
Sexual Behavior | 1 | 1999 | 2178 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3469 | 0.010 |
Why?
|
Vindesine | 1 | 1988 | 12 | 0.010 |
Why?
|
Health Surveys | 1 | 1999 | 4056 | 0.010 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2001 | 2151 | 0.010 |
Why?
|
Lomustine | 1 | 1988 | 60 | 0.010 |
Why?
|
Dactinomycin | 1 | 1988 | 304 | 0.000 |
Why?
|
Weight Loss | 1 | 2000 | 2683 | 0.000 |
Why?
|
Genetic Testing | 1 | 2001 | 3535 | 0.000 |
Why?
|
Parents | 1 | 2002 | 3563 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1977 | 1874 | 0.000 |
Why?
|
Health Promotion | 1 | 2000 | 2211 | 0.000 |
Why?
|
Canada | 1 | 1993 | 2119 | 0.000 |
Why?
|
Spinal Cord Neoplasms | 1 | 1989 | 263 | 0.000 |
Why?
|
Melphalan | 1 | 1988 | 420 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1997 | 1654 | 0.000 |
Why?
|
Drug Utilization | 1 | 1993 | 1188 | 0.000 |
Why?
|
Sleep | 1 | 2002 | 4760 | 0.000 |
Why?
|
Vincristine | 1 | 1988 | 1036 | 0.000 |
Why?
|
Cytokines | 1 | 2001 | 7377 | 0.000 |
Why?
|
Radiography | 1 | 1977 | 6963 | 0.000 |
Why?
|
Placenta | 1 | 1995 | 1704 | 0.000 |
Why?
|
Platelet Count | 1 | 1988 | 780 | 0.000 |
Why?
|
Pediatrics | 1 | 2000 | 3593 | 0.000 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1988 | 891 | 0.000 |
Why?
|
Endometriosis | 1 | 1993 | 869 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1988 | 1596 | 0.000 |
Why?
|
Prednisone | 1 | 1988 | 1564 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1998 | 11096 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11900 | 0.000 |
Why?
|
Cyclophosphamide | 1 | 1988 | 2218 | 0.000 |
Why?
|
Disease Progression | 1 | 2000 | 13484 | 0.000 |
Why?
|
Physicians | 1 | 2000 | 4586 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1982 | 398 | 0.000 |
Why?
|
Plasmapheresis | 1 | 1982 | 206 | 0.000 |
Why?
|
Substance-Related Disorders | 1 | 1998 | 4416 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1999 | 5421 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1998 | 9267 | 0.000 |
Why?
|
Plasma | 1 | 1982 | 585 | 0.000 |
Why?
|
Brain | 1 | 2005 | 27060 | 0.000 |
Why?
|
Brain Neoplasms | 2 | 1990 | 9003 | 0.000 |
Why?
|